CORPUS

Ce texte a une durée de lecture estimée à 55 minutes !5.1.11 Références

par Eric Rousseau
  1. Chua NH, et al. Differences in sensory processing between chronic cervical zygapophysal joint pain patients with and without cervicogenic headache. Cephalalgia 2011;31:953-963.
  2. Ashina M. Calcitonin gene-related peptide in tension-type headache. Scientific World J 2002;7(2):1527-31.
  3. Frese A, Schilgen M, Edvinsson L, Frandsen E, Evers S. Calcitonin gene-related peptide in cervicogenic headache. Cephalalgia 2005;25(9):700-3.
  4. Hubka MJ. Cervicogenic dysfunction in muscle contraction headache and migraine: a descriptive study. J manipul Physiol Ther 1993;16:428-431.
  5. Sjaastad O, Fredriksen T, Pareja Ja, et al. Coexistence of cervicogenic headache and migraine without aura. Funct Neurol 2000;14:209-218.
  6. Antonaci F, Fredriksen T, Sjaastad O. Cervicogenic headache: clinical presentation, diagnostic criteria and differential diagnosis. Curr Pain Headache Rep 2001;5:387-392.
  7. Sjaastad O, Fredriksen T, Pfaffenrath V. Cervicogenic headache: diagnostic criteria. Headache 1998;38:442-445.
  8. Cecchini AP, Sandrini G, Fokin I, et al. Trigeminofacial reflexes in primary headaches. Cephalalgia 2003;23:33-41.
  9. Milanov I, Bogdanova D. Trigemino-cervical reflex in patients with headache. Cephalalgia 2003:23:35-38.
  10. Nardone R, Tezzon F. The trigemino-cervical reflex in tension-type headache. Euro J Neurol 2003;10:307-312.
  11. Jull G, Amiri M, Bullock-Saxton J, et al. Cervical musculoskeletal impairment in frequent intermittent headache. Part 1: subjects with single headaches. Cephalalgia 2007;27:793-802.
  12. Jull G, Amiri M, Bullock-Saxton J, et al. Cervical musculoskeletal impairment in frequent intermittent headache. Part 2: subjects with multiple headaches. Cephalalgia 2007;27:891-898.
  13. Leone M, D’Amico D, Moschiano F, et al. Possible identification of cervicogenic headache among patients with migraine: an analysis of 374 headaches. Headache 1995;35:461-464
  14. Rokicki L, Semenchuk E, Bruehl S, et al. An examination of the validity of the IHS classification system for migraine and tension-type headache in the college student population. Headache 1999;39:720-727.
  15. Solomon S. Diagnosis of primary headache disorders: validity of the International Headache Society criteria in clinical practice. Neurol Clin 1997;15:15-26.
  16. Xiaobin Y, Cook A, Hamill-Ruth R, et al. Cervicogenic headache in patients with presumed migraine: missed diagnosis or misdiagnosis? J Pain 2005;6:700-703.
  17. Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 1991;46:125-132.
  18. Bendtsen L. Central sensitization in tension-type headache – possible pathophysiological mechanisms. Cephalalgia 2000;20:486-508.
  19. Matharu M, Bartsch T, Ward N, et al. Central neuromodulation in chronic migraine patients with suboccipital stimulators: a PET study. Brain 2004;127:220-230.
  20. Zito G, Jull G, Story I. Clinical tests of musculoskeletal dysfunction in the diagnosis of cervicogenic headache. Man Ther 2006;11:118-129.
  21. Zwart JA. Neck mobility in different headache disorders. headache 1997;37:6-11.
  22. Marcus DA, Scharff L, mercer S, et al. Musculoskeletal abnormalities in chronic headache: a controlled comparison of headache diagnostic groups. Headache 1999;39:21-27.
  23. International Headache Society Classification Subcommittee. International classification of headache disorders, 2nd edition. Cephalagie 2004;24(Suppl 1):1-160
  24. Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population – a prevaence study. J Clin Epidemiol 1991;44(11):1147-57.
  25. Hu XH, Markson LE, Lipton RB et al. Burden of migraine in the United States: disability and economic costs. Arch Intern Med 1999;159(8):813-18.
  26. Andermann E, Andermann FA. Migraine-epilepsy relationships : epidemiological and genetic aspects. In: Andermann FA, Lugaresi E, eds. Migraine and epilepsy. Boston: Butterworths, 1987:281-91.
  27. Breslau N, Schultz LR, Stewart WF et al. Headache and major depression: is the association specific to migraine? Neurology 2000;54:308-13.
  28. Breslau N, Davis GC, Andeski P. Migraine, psychiatric disorders and suicide attempts: an epidemiological study of young adults. Psychiatry Res 1991;37:11-23.
  29. Rothrock J, North J, Madden K et al. Migraine and migrainous stroke: risk factors and prognosis. Neurology 1993;43:2473-6.
  30. Welch KMA. Relationship of stroke and migraine. Neurology 1994;44(suppl 7):33-6.
  31. Bové FJ. The story of Ergot. New York: Karger, 1970.
  32. Woakes E. On ergot of rye in the treatment of neuralgia. Br Med J 1868;2:360-1.
  33. Silberstein SD. The pharmacology of ergotamine and dihydroergotamine. Headache 1997;37:S15-S25.
  34. Rapoport AM. Acute treatment of migraine: established and emerging therapies.  Headache 2012;52(Suppl 2):60-4.
  35. Johnston M, Rapoport AM. Triptans for the management of migraine. CNS Drugs 2010;70:1505-1518
  36. Tfelt-Hansen P, Hougaard A. Sumatriptan: a review of its pharmacokinetics, pharmacodynamics and efficacity in the acute treatment of migraine. Expert Opin Drug Metab Toxicol 2013;9(1):91-103.
  37. Tfelt-Hansen P. Over-the-counter triptans for migraine: what are the implications? CNS Drugs 2007;21(11):877-83.
  38. Minet ML, Massiou H. An instrument to assess patient perceptions of satisfaction with acute migraine treatment (EXPERT Study). Headache 2011;51(4):590-601.
  39. Lipton RB, Hamelsky SW, Dayno JM. What do patients with migraine want from acute migraine treatment? Headache 2002;42(Suppl 1):3-9.
  40. Lyndberg AC, Rasmussen BK, Jorgensen T, Jensen R. Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study. Eur J Epidemiol 2005;20(12):1007-14.
  41. Nappi G, Sandrini G, Sances G. Tolerability of the triptans: clinical implications. Drug Saf 2003;26(2):93-107.
  42. Dodick D, Lipton RB, Martin V et al. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache 2004;44(5):414-425.
  43. Lipton RB, Bigal ME, Diamond M et al. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68(5):343-349.
  44. Lucas C, Chaffaut C, Artaz MA, Lanteri-Minet M. FRAMIG 2000: medical and therapeutic management of migraine in France. Cephalalgia 2005;25(4):267–279.
  45. Morillo LE, Alarcon F, Aranaga N, et al. Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries. Headache 2005;45(2):118–126.
  46. Rizzoli PB. Acute and preventive treatment of migraine. Continuum 2012;18(4):764-82.
  47. Marcus DA, Scharff L, Mercer S, Turk DC. Nonpharmacological treatment for migraine: incremental utility of physical therapy with relaxation and thermal biofeedback. Cephalagia 1998;18(5):266-72.
  48. Parker GB, Tupling H, Pryor DS. A controlled trial of cervical manipulation for migraine. Aust NZJ Med 1978;8:589-593.
  49. Parker GB, Pryor DS, Tupling H. Why does migraine improve during a clinical trial? Further results from a trial of cervical manipulation for migraine. Aust NZB Med 1980;10:192-198.
  50. Nelson CF, Bronfort G, Evans R, Boline P, Goldsmith C, Anderson AV. The efficacity of spinal manipulations, amitryptiline and the combinaison of both therapies for the prophylaxis of migraine headache. J Manipulative Physiol Ther 1998;21:511-519.
  51. Tuchin PJ, Pollard H, Bonello R. A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. J Manipulative Physiol Ther 2000;23:91-95.
  52. Chaibi A, Tuchin PJ, Russel MB. Manual therapy for migraine: a systematic review. J Headache Pain 2011;12:127-133.
  53. Bartsch T, Goadsby PJ. The trigeminocervical complex and migraine : current concepts and synthesis. Curr Pain Headache Reports 2003;7:371-376.
  54. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack. Brain 2000;123:1703-1709.
  55. Bernstein C, Burstein R. Sensitization of the trigeminovascular pathway: perspective and implications to migraine pathophysiology. J Clin Neurol 2012;8:89-99.
  56. Strassman AM, Raymond SA, Burstein R. Sensitization of meningeal sensory neurons and the origin of headaches. Nature 1996;384:560-563.
  57. Olesen J, Burstein R, Ashina M, Tfelt-Hansen P. Origin of pain in migraine : evidence for peripheral sensitisation. Lancet 2009;8:679-690.
  58. Tommaso M, Sardaro M, Vecchio E, Serpino C, Stasi M, Ranieri M. Central sensitisation phenomena in primary headaches : overview of a preventive therapeutic approach. CNS Neurol Disord Drug Targets 2008;7:524-535.
  59. Bartsch T, Goadsby PJ. Stimulation of the greater occiptal nerve induces inceased central excitability of dural afferent input. Brain 2002;125:1496-1509.
  60. Bartsch T, Goadsby PJ. Increased response in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain 2003;126:1801-1813.
  61. Robertson BA, Moris ME. The role of cervical dysfunctions in migraine: a systematic review. Cephalagia 2008;28:474-483.
  62. Yi X, Cook AJ, Hamill-Ruth RJ, Rowlingson JC. Cervicogenic headache in patients with presumed migraine : missed diagnosis or misdiagnosis? J Pain 2005;6:700-703.
  63. Piovesan EJ, Werneck LC, Kowacs PA, Tatsui CE, Lange MC, Vincent M. Anesthetic blockade of the greater occipital nerve in migraine prophylaxis. Arg Neuropsiquiatr 2001;59:545-551.
  64. Weiner RL. Occipital neurostimulation for treatment of intractable headache syndrome. Acta Neurochir 2007;97:129-133.
  65. Weiner RL, Reed KL. Peripheral neurostimulation for control of intractable occipital neuralgia. Int Neuromod Society 1999;2:217-221.
  66. Magis D, Gerardy PY, Remacle JM, Schoenen J. Sustained effectiveness of occipital nerve stimulation in drug-resistant chronic cluster headache. Headache 2011;51:1191-1201.
  67. Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type headache. Headache 2012;52:1226-1235.
  68. Luedtke K, Allers A, Schulte LH, May A. Efficacy of interventions used by physiotherapists for patients with headache and migraine: systematic review and meta-analysis. Cephalagia 2016;36:474-492.
  69. Luedtke K, Boissonnault W, Caspersen N, Castien R, Chaibi A, Falla D, et al. International consensus on the most useful physical examination tests used by physiotherpists for patients with headache: A Delphi study. Man Ther 2016;23:17-24.
  70. Robertson BA, Morris ME. The role of cervical dysfunction in migraine: a systematic review. Cephalalgia 2008;28:474-483.
  71. Ashina S, Bendtsen L, Lyngberg AC, Lipton RB, Hajiyeva N, Jensen R. Prevalence of neck pain in migraine and tension-type headache: a population study. Cephalalgia 2015;35:211-219.
  72. Vincent MB. Headache and neck. Curr Pain Headache Rep 2011;15:324-331.
  73. Evoy F. Vertiges d’origine centrale : sans anamnèse ni examen physique, point de diagnostic. Le Médecin du Québec 2005;40:33-41
  74. Bédard J. Vertiges vestibulaires périphériques : solutions et résolutions. Le Médecin du Québec 2005;40:45-52.
  75. Bédard J. Étourdissements et syncopes : comment ne pas tourner en rond? Le Médecin du Québec 2005;40:27-30.
  76. Clavet D. Vous dites que l’anxiété me rend étourdi, docteur? Le Médecin du Québec 2005;40:71-80.
  77. Wolff HG. Headache and Other Head Pain. 1948; New York: Oxford University Press.
  78. Wirth FP, van Buren JM. Referral of pain from dural stimulation in man. J Neurosurg 1971;34:630-642.
  79. Bartsch T, Goadsby PJ. Stimulation of the greater occipital nerve induces increased central excitability of dural afferent input. Brain 2002;125:1496-1509.
  80. Kaube H, Katsarava Z, Kaufer T, Diener HC, Ellrich J. A new method to increase the nociception specificity of the human blink reflex. Clin Neurophysiol 2000;111:413-416.
  81. Li J, Simone DA, Larson AA. Windup leads to characteristics of central sensitization. Pain 1999;79:75-82.
  82. Cervero F. Fine afferent fibres from viscera and visceral pain: Anatomy and physiology of viscero-somatic convergence. In: Schmidt RF, Schaible HG, Vahle-Hinz C. Fine Afferent Nerve Fibers And Pain. 1987; Weinheim, Germany: VCH.
  83. Cervero F, Laird JM. Visceral Pain. Lancet 1999;353:2145-2148.
  84. Herrero JF, Laird JM, Lopez-Garcia JA. Wind-up of spinal cord neurones and pain sensation: Much ado about something? Prog Neurobiol 2000;61:169-203.
  85. Bolton S, O’Shaughnessy CT, Goadsby PJ. Properties of neurons in the trigeminal nucleus caudalis responding to noxious dural and facial stimulation. Brain Res 2005;1046:122-129.
  86. Bronfort G, Nilsson N, Haas M, et al. Non-invasive physical treatments for chronic/recurrent headache. Cochrane Database Syst Rev 2004;3:CD001878.
  87. Biondi DM. Physical treatments for headache: A structured review. Headache 2005;45:738-746.
  88. Fernandez-de-las-Penas C, Alonos-Blanco C, Cuadrado ML, Miangolarra JC, Barriga FJ, Pareja JA. Are manual therapies effective in reducing pain from tension-type headache? A systematic review. Clin J Pain 2006;22:278-285.
  89. Global Burden of Disease Study 2013 Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study. Lancet 2015;386:743-800.
  90. Pearce JMS. Historical aspects of migraine. J Neurol Neurosurg Psych 1986;49:1097-1103.
  91. Sacks O. Migraine: Evolution of a common disorder. 1970; Londres: Faber & Faber.
  92. Lyons A, Petrucelli RJ. Medicine: an illustrated history. 1978; New York: Harry N. Abrams Inc.
  93. Silberstein SD, McCrory DC. Ergotamine and dihydroergotamine: history, pharmacology, and efficacy. Headache 2003;43:144–166.
  94. Silberstein SD. The pharmacology of ergotamine and dihydroergotamine. Headache 1997;37:S15-S25.
  95. Silberstein SD, Lipton R, Goadsby P. Headache in Clinical Practice 2nd Edition. 2002; Informa HealthCare.
  96. Moskowitz MA. The visceral organ brain: Implications for the pathophysiology of vascular head pain. Neurology 1991;41:182-186.
  97. Mehle ME. Migraine and allergy: A review and clinical update. Curr Allergy Asthma Rep 2012;12:240-245.
  98. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition (Beta version). Cephalalgia 2013;33:629-808.
  99. Prakash S, Rathore C, Makwana P, Rathod M. Recurrent spontaneous paresthesia in the upper limb could be due to migraine: A case series. Headache 2015;55:1143-1147.
  100. Dubé Y. Ces yeux qui nous parlent. Le Médecin du Québec 2007;42:21-29.
  101. Winawer MR, Connors R. Evidence for a shared genetic susceptibility to migraine and epilepsy. Epilepsia 2013;54:288-295.
  102. Mantegazza M, Cestèle S. Pathophysiological mechanisms of migraine and epilepsy: Similarities and differences. Neurosci Lett 2017:S0304-S3940 [Epub ahead of print].
  103. Couch JR, Diamond S. Status migrainosus: causative and therapeutic aspects. Headache 1983;23:94-101.
  104. Katsarava Z, Schneeweiss S, Kurth H et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004;62:788-790.
  105. Scher AI, Stewart WF, Ricci JA et al. Factors associated with the onset and remission of chronic daily headache in a population-based study. Pain 2003;106:81-89.
  106. Solomon S, Lipton RB, Newman LC. Clinical features of chronical daily headache. Headache 1992;32:325-329.
  107. Tzourio C, Iglesias S, Tehindrazanarivelo A et al. Migraine and ischemic stroke in young women. Stroke 1994;25:15.
  108. Alvarez J, Matias-Guiu J, Sumulla J. Ischemic stroke in young adults: analysis of etiological subgroups. Acta Neurol Scand 1989;80:29-34.
  109. Bale JL. Les céphalées primaires de l’enfant: Diagnostic et traitement. Paediatrica 2007;18:39-44.
  110. Winner P, Hershey AD. Diagnosing migraine in the pediatric population. Curr Pain Headache Reports 2006;10:363-369.
  111. Lewis DW. Pediatric Migraine. Pediatrics in Review 2007;28:43-53.
  112. Balottin U, Termine C, Nicoli F, et al. Idiopathic headache in children under six years of age: A follow-up study. Headache 2005;45:705-715.
  113. Stolte B, Holle D, Naegel S, Diener HC, Obermann M. Vestibular migraine. Cephalalgia 2015;35:262-270.
  114. Lauritsen CG, Marmura MJ. Current treatment options: Vestibular migraine. Curr Treat Options Neurol 2017;19:38.
  115. Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache 2007;47:1427-1435.
  116. Faucher S, Le Heuzey MF, Rouyer V, Mouren-Simeoni MC. À propos du syndrome des vomissements cycliques. Archives de pédiatrie 2003;10:385-391.
  117. Bisdorff AR. Management of vestibular migraine. Ther Adv Neurol Disord 2011;4:183-191.
  118. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol 2009;22:269-276.
  119. Stewart WF, Lipton RB, Celentano DD, Reed ML. Prevalence of migraine headache in the United States: Relation to age, income, race, and other sociodemographic factors. JAMA 1992;267:64-69.
  120. May A, Schulte LH. Chronic migraine: Risk factors, mechanisms and treatment. Nature Reviews 2016;12:455-464.
  121. Buse DC, et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study. Headache 2012;52:1456-1470.
  122. Stovner L, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalagia 2007; 27:193-210.
  123. Gilmour H, Ramage-Morin PL. Prevalence of migraine in the Canadian household population. https://www.statcan.gc.ca/pub/82-003-x/2014006/article/14033-eng.htm. Visité le 23 novembre 2017.
  124. Sharav Y, Benoliel R. Orofacial Pain and Headache. 2008; Mosby.
  125. Netter FH. The Netter’s Collection of Medical Illustrations Vol. 7 The Nervous System, Part I: The Brain, 2nd Edition 2013; Philadelphia: Elsevier Saunders.
  126. Silberstein SD, Stiles A, Young WB, Rozen TD. An Atlas of Headache. 2002 : The Parthenon Publishing Group.
  127. Pellegrino ABW, Davis-Martin RE, Houle TT, Smitherman TA. Perceived triggers of primary headache disorders: A meta-analysis. Cephalalgia 2017;333102417727535 [Epub ahead of print].
  128. Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: A systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci 2017;372:307-315.
  129. Cutrer FM, Moskowitz MA. Physiopathologie de la migraine. 2005; Paris.
  130. Gatt MT, Belin C. Migraines: Points de vue d’un neurologue et d’un médecin de la douleur. Revue Française Psychosom 208;34:87-96.
  131. Goadsby PJ, Holland PR, Martins-Oliveira M, et al. Pathophysiology of migraine: A disorder of sensory processing. Physiol Rev 2017;97:553-622.
  132. Charles A. Migraine: A brain state. Curr Opin Neurol 2013;26:235-239.
  133. Ferrari MD, Klever RR, Terwindt GM, et al. Migraine pathophysiology: Lessons from mouse models and human genetics. Lancet Neurol 2015;14:65-80.
  134. Puledda F, Messina R, Goadsby PJ. An update on migraine: Current understanding and future directions J Neurol 2017;264:2031-2039.
  135. Goadsby PJ, Hoskin KL. The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: A c-Fos immunocytochemical study. J Anat 1997;190(Pt 3):367-375.
  136. Hoskin KL, Zagami A, Goadsby PJ. Stimulation of the middle meningeal artery leads to Fos expression in the trigeminocervical nucleus: A comparative study of monkey and cat. J Anat 1999;194:579-588.
  137. Messlinger K, Fischer MJ, Lennerz JK. Neuropeptide effects in the trigeminal system: Pathophysiology and clinical relevance in migraine. Keio J Med 2011;60:82-89.
  138. Ho TW, Edvinsson L, Goadsby PJ. CGRP and its receptors provide new insights into migraine pathophysiology. Nat Rev Neurol 2010;6:573-582.
  139. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience 2009;161:327-341.
  140. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011;12:570-584.
  141. Moskowitz MA, Cutrer FM. Sumatriptan: A receptor-targeted treatment for migraine. Annu Rev Med 1993;44:145-154.
  142. Markowitz S, Saito K, Moskowitz MA. Neurogenically mediated leakage of plasma proteins occurs from blood vessels in dura mater but not brain. J Neurosci 1987;7:4129-4136.
  143. May A, Goadsby PJ. Substance P receptor antagonists in the therapy of migraine. Expert Opinion Investig Drugs 2001;10:1-6.
  144. Peroutka SJ. Neurogenic inflammation and migraine: Implications for therapeutics. Mol Interv 2005;5:306-313.
  145. Raskin NH, Hosobuchi Y, Lamb S. Headache may arise from perturbation of brain. Headache 1987;27:416-420.
  146. Weiller C, May A, Limmroth V, Juptner M, et al. Brain stem activation in spontaneous human migraine attacks. Nat Med 1995;1:658-660.
  147. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001;357:1016-1017.
  148. Stankewitz A, Aderjan D, Eippert F, May A. Trigeminal nociceptive transmission in migraineurs predicts migraine attacks. J Neurosci 2011;31:1937-1943.
  149. Goadsby PJ, Duckworth JW. Low frequency stimulation of the locus coeruleus reduces regional cerebral blood flow in the spinalized cat. Brain Res 1989;476:71-77.
  150. Vinogradova LV. Comparative potency of sensory-induced brainstem activation to trigger spreading depression and seizures in the cortex of awake rats: Implications for the pathophysiology of migraine aura. Cephalalgia 1995;35:979-986.
  151. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci 2011;12:570-584.
  152. Borsook D, Burstein R. The enigma of the dorsolateral pons as a migraine generator. Cephalalgia 2012;32:803-812.
  153. Kroger IL, May A. Triptan-induced disruption of trigemino-cortical connectivity. Neurology 2015;84:2124-2131.
  154. Goadsby PJ, Hoskin KL. Inhibition of trigeminal neurons by intravenous administration of the serotonin (5HT)1B/D receptor agonist zolmitriptan (311C90): Are brain stem sites therapeutic target in migraine? Pain 1996;67:355-359.
  155. Goadsby PJ, Gundlach AL. Localization of 3H-dihydroergotamine-binding sites in the cat central nervous system: Relevance to migraine. Ann Neurol 1991;29:91-94.
  156. Hoskin KL, Kaube H, Goadsby PJ. Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain 1996;119(Pt 1):249-256.
  157. Pozo-Rosich P, Storer RJ, Charbit AR, Goadsby PJ. Periaqueductal gray calcitonin gene-related peptide modulates trigeminovascular neurons. Cephalalgia 2015;35:1298-1307.
  158. Storer RJ, Akerman S, Goadsby PJ. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol 2004;142:1171-1181.
  159. May A, Bahra A, Buchel C, Frackowiak RS, Goadsby PJ. Hypothalamic activation in cluster headache attacks. Lancet 1998;352:275-278.
  160. Goadsby PJ. Trigeminal autonomic cephalalgias. Continuum 2012;18:883-895.
  161. May A. Cluster headache: Pathogenesis, diagnosis, and management. Lancet 2005;366:843-855.
  162. Kagan R, Kainz V, Burstein R, Noseda R. Hypothalamic and basal ganglia projections to the posterior thalamus: Possible role in modulation of migraine headache and photophobia. Neuroscience 2013;248:359-368.
  163. Abdallah K, Artola A, Monconduit L, Dallel R, Luccarini P. Bilateral descending hypothalamic projections to the spinal trigeminal nucleus caudalis in rats. PLoS One 2013;8:e73022.
  164. Robert C, Bourgeais L, Arreto CD, et al. Paraventricular hypothalamic regulation of trigeminovascular mechanisms involved in headaches. J Neurosci 2013;33:8827-8840.
  165. Moulton EA, Becerra L, Johnson A, Burstein R, Borsook D. Altered hypothalamic functional connectivity with autonomic circuits and the locus coeruleus in migraine. PLoS One 2014;9:e95508.
  166. Denuelle M, Fabre N, Payoux P, Chollet F, Geraud G. Hypothalamic activation in spontaneous migraine attacks. Headache 2007;47:1418-1426.
  167. Maniyar FH, Sprenger T, Monteith T, Schankin C, Goadsby PJ. Brain activations in the premonitory phase of nitroglycerin-triggered migraine attacks. Brain 2014;137:232-241.
  168. Schulte LH, May A. The migraine generator revisited: Continuous scanning of the migraine cycle over 30 days and three spontaneous attacks. Brain 2016;139:1987-1993.
  169. Oliveira MM, Akerman S, Tavares I, Goadsby PJ. Neuropeptide Y inhibits the trigeminovascular pathway through NPY Y1 receptor: Implications for migraine. Pain 2016;157:1666-1673.
  170. Noseda R, Jakubowski M, Kainz V, Borsook D, Burstein R. Cortical projections of functionally identified thalamic trigeminovascular neurons: Implications for migraine headache and its associated symptoms. J Neurosci 2011;31:14204-14217.
  171. Noseda R, Kainz V, Borsook D, Burstein R. Neurochemical pathways that converge on thalamic trigeminovascular neurons: Potential substrate for modulation of migraine by sleep, food intake, stress and anxiety. PLoS One 2014;9:e103929.
  172. Messina R, Rocca MA, Colombo B, et al. White matter microstructure abnormalities in pediatric migraine patients. Cephalalgia 2015;35:1278-1286.
  173. Coppola G, Tinelli E, Lepre C, Iacovelli E, et al. Dynamic changes in thalamic microstructure of migraine without aura patients: a diffusion tensor magnetic resonance imaging study. Eur J Neurol 2014;21:287-e13.
  174. Magon S, May A, Stankewitz A, Goadsby PJ, et al. Morphological abnormalities of thalamic subnuclei in migraine: A multicenter MRI study at 3 tesla. J Neurosci 2015;35:13800-13806.
  175. Porcaro C, Di Lorenzo G, Seri S, Pierelli F, Tecchio F, Coppola G. Impaired brainstem and thalamic high-frequency oscillatory EEG activity in migraine between attacks. Cephalalgia 2017;37:915-926.
  176. Hodkinson DJ, Wilcox SL, Veggeberg R, et al. Increased amplitude of thalamo-cortical low-frequency oscillations in patients with migraine. J Neurosci 2016;36:8026-8036.
  177. Afridi SK, Matharu MS, Lee L, Kaube H, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005;128:932-939.
  178. Afridi SK, Giffin NJ, Kaube H, et al. A positron emission tomographic study in spontaneous migraine. Arch Neurol 2005;62:1270-1275.
  179. Noseda R, Kainz V, Jakubowski M, Gooley JJ, et al. A neural mechanism for exacerbation of headache by light. Nat Neurosci 2010;13:239-245.
  180. Burstein R, Jakubowski M, Garcia-Nicas E, et al. Thalamic sensitization transforms localized pain into widespread allodynia. Ann Neurol 2010;68:81-91.
  181. Shields KG, Goadsby PJ. Propranolol modulates trigeminovascular responses in thalamic ventroposteromedial nucleus: A role in migraine? Brain 2005;128:86-97.
  182. Tepe N, Filiz A, Dilekoz E, Akcali D, Sara Y, Charles A, Bolay H. The thalamic reticular nucleus is activated by cortical spreading depression in freely moving rats: Prevention by acute valproate administration. Eur J Neurosci 2015;41:120-128.
  183. Andreou AP, Shields KG, Goadsby PJ. GABA and valproate modulate trigeminovascular nociceptive transmission in the thalamus. Neurobiol Dis 2010;37:314-323.
  184. Summ O, Charbit AR, Andreou AP, Goadsby PJ. Modulation of nocioceptive transmission with calcitonin gene-related peptide receptor antagonists in the thalamus. Brain 2010;133:2540-2548.
  185. Bhaskar S, Saeidi K, Borhani P, Amiri H. Recent progress in migraine pathophysiology: Role of cortical spreading depression and magnetic resonance imaging. Eur J Neurosci 2013;38:3540-3551.
  186. Hadjikhani N, Sanchez Del Rio M, Wu O, et al. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci USA 2001;98:4687-4692.
  187. Ayata C, Lauritzen M. Spreading depression, spreading depolarizations, and the cerebral vasculature. Physiological Reviews 2015;95:953-993.
  188. Santos E, Schöll M, Sánchez-Porras R, et al. Radial, spiral and reverberating waves of spreading depolarization occur in the gyrencephalic brain. NeuroImage 2014;99:244-255.
  189. Terra VC, Cysneiros R, Cavalheiro EA, Scorza FA. Sudden unexpected death in epilepsy: From the lab to the clinic setting. Epilepsy & Behavior 2013;26:415-20.
  190. Sprenger T, Borsook D. Migraine changes the brain: Neuroimaging makes its mark. Curr Opin Neurol 2012;25:252-262.
  191. Chong CD, Schwedt TJ, Dodick DW. Migraine: What imaging reveals. Curr Neurol Neurosci Rep 2016;16:64.
  192. Coppola G, Di Lorenzo C, Schoenen J, Pierelli F. Habituation and sensitization in primary headaches. J Headache Pain 2013;14:65
  193. Ambrosini A, Rossi P, De Pasqua V, Pierelli F, Schoenen J. Lack of habituation causes high intensity dependence of auditory evoked cortical potentials in migraine. Brain 2003;126:2009-2015.
  194. Afra J, Cecchini AP, De Pasqua V, Albert A, Schoenen J. Visual evoked potentials during long periods of pattern-reversal stimulation in migraine. Brain 1998;121(Pt 2):233-241.
  195. Andreou AP, Holland PR, Akerman S, Summ O, Fredrick J, Goadsby PJ. Transcranial magnetic stimulation and potential cortical and trigeminothalamic mechanisms in migraine. Brain 2016;139:2002-2014.
  196. Lipton RB, Dodick DW, Silberstein SD, et al. Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: A randomised, double-blind, parallel-group, sham-controlled trial. Lancet Neurol 2010;9:373-380.
  197. Bolay H, Reuter U, Dunn AK, Huang Z, Boas DA, Moskowitz MA. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med 2002;8:136-142.
  198. Zhang X, Levy D, Kainz V, Noseda R, Jakubowski M, Burstein R. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol 2011;69:855-865.
  199. Piane M, Lulli P, Farinelli I, Simeoni S, et al. Genetics of migraine and pharmacogenomics: Some considerations. The journal of headache and pain 2007;8:334-339.
  200. Gasparini CF, Smith RA, Griffiths LR. Genetic insights into migraine and glutamate: A protagonist driving the headache. J Neurol Sci 2016;367:258-268.
  201. Freilinger T, Anttila V, de Vries B, Malik R, et al. Genome-wide association analysis identifies susceptibility loci for migraine without aura. Nat Genet 2012;44:777-782.
  202. Estevez M, Gardner KL. Update on the genetics of migraine. Hum Genet 2004;114:225-235.
  203. Nelson CF. The tension headache, migraine headache continuum: A hypothesis. J Manipulative Physiol Ther 1994;17:156-67.
  204. Peres MFP, Gonçalves AL, Krymchantowski A. Migraine, Tension-type Headache, and Transformed Migraine. Curr Pain Headache Rep 2007;11:449-453.
  205. Shevel E. The migraine/tension-type headache continuum. South Afric Med J 2000;90:869-871.
  206. Vincent MB, Luna RA. Cervicogenic headache: A comparison with migraine and tension-type headache. Cephalalgia 1999;19(Suppl 25):11-16.
  207. Pryse-Phillips W, Findlay H, Tugwell P, et al. A Canadian population survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can J Neurol Sci 1992;19:333-339.
  208. Lyngberg AC, Rasmussen BK, Jorgensen T, Jensen R. Incidence of primary headache: A Danish epidemiologicfollow-up study. Am J Epidemiol 2005;161:1066-1073.
  209. Robertson BA, Morris ME. The role of cervical dysfunction in migraine: A systematic review. Cephalalgia 2008;28:474-483.
  210. Luedtke K, Starke W, May A. Musculoskeletal dysfunction in migraine patients. Cephalalgia 2017:333102417716934 [Epub ahead of print].
  211. Florencio LL, de Oliveira AS, Carvalho GF, Dach F, et al. Association Between Severity of Temporomandibular Disorders and the Frequency of Headache Attacks in Women With Migraine: A Cross-Sectional Study. J Manipul Physiol Ther 2017;40:250-254.
  212. Bogduk N. The anatomical basis for cervicogenic headache. J Manipulative Physiol Ther 1992;15:67-70.
  213. Becker WJ. Cervicogenic headache: evidence that the neck is a pain generator. Headache 2010;50:699-705.
  214. Hunter CR, Mayfield FH. Role of the upper cervical roots in the production of pain in the head. Am J Surg 1949;78:743-749.
  215. Johnston M, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: Implications for headache disorders. Ann Neurol 2013;74:145-8.
  216. Cremer P, halmagyi GM, Goadsby PJ. Secondary cluster headache responsive to sumatriptan. J Neurol Neurosurg Psychiatry 1995;59:633-34.
  217. Hutchinson PJ, Pickard JD, Higgins JN. Vertbral artery dissection presenting as cerebellar infarction. J Neurol Neurosurg Psychiatry 2000;68:98-99.
  218. Piovesan EJ, Kowacs PA, Tatsui CE, et al. Reffered pain after painful stimulation of the greater occipital nerve in humans: Evidence of convergence of cervical afferents on trigeminal nuclei. Cephalagia 2001;21:107-109.
  219. Feinstein B, Langton JN, Jameson RM, Schiller F. Experiments on pain reffered from deep somatic tissues. J Bone Joint Surg 1954;36-A:981-997.
  220. Bogduk N. Cervicogenic headache: Anatomical basis and pathophysiology mechanisms. Curr Pain Headache Rep 2001;5:382-386.
  221. von Piekartz, Hall T. Orofacial manual therapy improves cervical movement impairment associated with headache and features of temporomandibular dysfunction: a randomized controlled trial. Man Ther 2013;18:345-50.
  222. von Piekartz, Ludtke K. Effect of treatment of temporomandibular disorders (TMD) in patients with cervicogenic headache: a single-blind, randomized controlled study. Cranio 2011;29:43-56.
  223. DeFranca GG, Levine LJ. « The T4 syndrome. » J Manipulative Physiol Ther 1995;18:34-7.
  224. Schueler M, Neuhuber WL, de Col R, Messlinger K. Inervation of rat and human dura mater and pericranial tissues in the parieto-temporal region by meningeal afferents. Headache 2014;54:996-1009.
  225. Butler DS. The sensitive Nervous System. 2000; Adelaide: NOI Group.
  226. Joel Saper. Neck and Migraine: What’s the connection? https://www.migraineworldsummit.com/public-joel-saper. Accédé le 28 avril 2017.
  227. Thorsten B, Goadsby PJ. The trigeminocervical complex and migraine. In: Fernandez-de-las-Penas C, Chaitow L, Schoenen J. Multidisciplinary management of migraine. 2013; Burlington MA: Jones & Bartlett Learning.
  228. Behbehani MM. Functionnal characeristics of the midbrain periaqueductal gray. Prog Neurobiol 1995;46:575-605.
  229. Fields H. State-dependant opioid control of pain. Nat Rev Neurosci 2004;5:565-575.
  230. SandKuhler J, Fu QG, Zimmermann M. Spinal pathways mediating tonic or stimulation-produced descending inhibition from the periaqueductal gray or nucleus raphe magnus are separate in the cat. J Neurophysiol 1987;58:327-341.
  231. de Tomasso M, Capuano A, Valeriani M. Peripheral and central sensitization mechanisms in migraine. In: Fernandez-de-las-Penas C, Chaitow L, Schoenen J. Multidisciplinary management of migraine. 2013; Burlington MA: Jones & Bartlett Learning.
  232. Giniatullin R, Nistri A, Fabbretti E. Molecular mechanisms of sensitization of pain-transducing P2X3 receptors by the migraine mediators CGRP and NGF. Mol Neurobiol 2008;37:83-90.
  233. Crépel F, Lemaire G. Le monoxyde d’azote. Revue MS 1995;11:1639-1642.
  234. Thomsen LL, Olesen J. Nitric oxide in primary headaches. Curr Opin Neurol 2001;14:315-321.
  235. Akerman S, Williamson DJ, Kaube H, Goadsby PJ. Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural miningeal vessels. Br J Pharmacol 2002;137:62-68.
  236. Lambert Ga, Boers PM, Hoskin KL, Donaldson C, Zagami AS. Suppression by eletriptan of the activation of trigeminovascular sensory neurons by glyceryltrinitrate. Brain Res 2002;953:181-188.
  237. Borkum JM. Migraine Triggers and Oxidative Stress: A Narrative Review and Synthesis. Headache 2016;56:12-35.
  238. Isler H. Thomas Willis’ chapters on headache of 1672. Headache 1986;25:95-98.
  239. Schoonman GG, van der Grond J, Kortmann C, et al. Migraine headache is not associated with cerebral or meningeal vasodilatation: A 3T magnetic resonance angiography study. Brain 2008;131:2192-2200.
  240. Schoenen J, Ambrosini A, Sandor PS, Maertens de Noordhout A. Evoked potentials ans transcranial magnetic stimulation in migraine: Published data and viewpoint on their pathophysiologic signifiance. Clin Neurophysiol 2003;114:955-972.
  241. Aurora SK, Barrodale P, Chronicle EP, Mulleners WM. Cortical inhibition is reduced in chronic and episodic migraine and demonstrated a spectrum of illness. Headache 2005;45:546-552.
  242. Coppola G, Ambrosini A, Di Clemente L, et al. Interictal abnormalities of gamma band activity in visual evoked responses in migraine: An indication of thalamocortical dysrhytmia? Cephalalgia 2007;27:1360-1367.
  243. Gantenbein A, Sandor P, Riederer F, Schoenen J. A comprehensive view of migraine pathophysiology. In: Fernandez-de-las-Penas C, Chaitow L, Schoenen J. Multidisciplinary management of migraine. 2013; Burlington MA: Jones & Bartlett Learning.
  244. Pardutz A, Multon S, Malgrange B, et al. Effect of nitroglycerin on CGRP and 5-HTafferents to rat caudal spinal trigeminal nucleus and its modulation by oestrogen. Eur J Neurosci 2002;15:1803-1809.
  245. Multon S, Pardutz A, Mosen J, et al. Lack of oestrogen increases pain in the trigeminal formalin model: A behavioural and immunocytochemical study of transgenic ArKO mice. Pain 2005;114:257-265.
  246. Gupta S, Mehrotra S, Villalon CM, et al. Potntial role of female sex hormones in the pathophysiology of migraine. Pharmacol Therap 2007;113:321-340.
  247. MacGregor EA. Menstrual migraine. Curr Opin Neurol 2008;21:309-315.
  248. Letizia-Mauro G, Cataldo P, Barbera G, Sanfilippo A. α-Lipoic acid and superoxide dismutase in the management of chronic neck pain: A prospective randomized study. Drugs in R&D 2014;14:1-7.
  249. Alp R, Selek S, Alp IS, Taşkin A, Koçyigit A. Oxidative and antioxidative balance in patients of migraine. Eur Rev Med Pharm Sci 2010;14:877-882.
  250. Kolberg C, Horst A, Moraes MS, et al. Peripheral oxidative stress blood markers in patients with chronic back or neck pain treated with high-velocity, low-amplitude manipulation. J Manipul Physiol Ther 2015;38:119-129.
  251. Ford ES, Li C, Pearson WS, Zhao G, Strine TW, Mokdad AH. Body mass index and headaches: findings from a national sample of US adults. Cephalalgia 2008;28:1270-1276.
  252. Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and Migraine: The Effect of Age, Gender and Adipose Tissue Distribution. Headache 2010;50:52-62.
  253. Bigal ME, Liberman JN, Lipton RB. Obesity and migraine: a population study. Neurology 2006;66:545-550.
  254. Bigal ME, Lipton RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache. Neurology 2006;67:252-257.
  255. Bigal ME, Tsang A, Loder E, Serrano D, Reed ML, Lipton RB. Body mass index and episodic headaches: a population-based study. Arch Intern Med 2007;167:1964-1970.
  256. Schuster NM, Rapoport AM. New strategies for the treatment and prevention of primary headache disorders. Nature Reviews Neurology 2016;12:635-650.
  257. Bharadwaj VN. Porreca F, Cowan RP, et al. A new hypothesis linking oxytocin to menstrual migraine. Headache 2021;61:1051-1059.
  258. Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Current Opinion in Neurology. 2011;24:197-202.
  259. Noseda R, Melo-Carrilo A, Nir R-R, et al. Non-trigeminal nociceptive innervation of the posterior dura: Implications to occipital headache. J Neurosci 2019;39:1867-1880.
  260. Lv X, Wu Z, Li Y. Innervation of the cerebral dura mater. Neuroradiol J 2014;27:293-298.
  261. Waldie KE, Buckley J, Bull PN, Poulton R. Tension-type headache: A life-course review. J Headache Pain Manag 2015;1:1.
  262. de Goffau MJ, Klaver ARE, Willemsen MG, Bindels PJE, Verhagen AP. The Effectiveness of Treatments for Patients With Medication Overuse Headache: A Systematic Review and Meta-Analysis. Pain 2017;18:615-627.
  263. Munksgaard SB, Bendtsen L, Jensen RH. Detoxification of medication-overuse headache by a multidisciplinary treatment programme is highly effective: A comparison of two consecutive treatment methods in an open-label design. Cephalalgia 2012;32:834-844.
  264. Sanchez-Manso JC, Aleksenko D. Headache, medication Overuse. 2017; StatPearls.
  265. Clinch CR. Evaluation of acute headaches in adults. Am Fam Phys 2001;63:685-692.
  266. Gormley P, Anttila V, Winsvold BS, et al. Meta-analysis of 375,000 individuals identifies 38 susceptibility loci for migraine. Nat Genet 2016;48:856-866.
  267. Nyholt DR, van den Maagdenberg AM. Genome-wide association studies in migraine: Current state and route to follow. Curr Opin Neurol 2016;29:302-308.
  268. Peris F, Donoghue S, Torres F, et al. Towards improved migraine management : Determining potential trigger factors in individual patients. Cephalalgia 2017;37:452-463.
  269. Watson DH, Drummond PD. Head pain referral during examination of the neck in migraine and tension-type headache. Headache J Head face Pain 2012;52:1226-1235.
  270. Ogince M, Hall T, Robinson K, et al. The diagnostic validity of the cervical flexion-rotation test in C1/2-related cervicogenic headache. Man Ther 2007;12:256-262.
  271. Russo A, Silvestro M, Tessitore A, Tedeschi G. Recent insights in migraine with aura : A narrative review of advanced neuroimaging. Headache 2019;59:637-649.
  272. Nahman-Averbuch HN, Shelfi T, Schneider VJ, et al.  Quantitative sensory testing in patients with migraine: A systematic review and meta-analysis. Pain 2018;159:1202-1223.
  273. Schueler M, Messlinger K, Dux M, Neuhuber WL, De Col R. Extracranial projections of meningeal afferents and their impact on meningeal nociception and headache. Pain 2013;154:1622-1631.
  274. Burstein R, Blake P, Schain A, Perry C. Extracranial origin of headache. Curr Opin Neurol 2017;30:263-271.
  275. Jakubowski M, et al. Exploding vs imploding headache in migraine prophylaxis with Botulinum toxin A. Pain 2006;125:286-295.
  276. Zhang X, Levy D, Noseda R, Kainz V, Jakubowski M, Burstein R. Activation of meningeal nociceptors by cortical spreading depression: Implications for migraine with aura. J Neurosci 2011;30:8807-8814.
  277. Roch M, Messlinger K, Kulchitsky V, et al. Ongoing activity in trigeminal wide-dynamic range neurons is driven from the periphery. Neurosci 2007;150:681-691.
  278. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001;120:3779-3787.
  279. Goadsby PJ, Bartsch T. On the functional neuroanatomy of neck pain. Cephalalgia 2008;28(Suppl 1):1-7.
  280. Nöbel M, Feistel S, Ellrich J, Messlinger K. ATP-sensitive muscles afferents activate spinal trigeminal neurons with meningeal afferent input in rat – pathophysiological implications for tension-type headache. J Headache Pain 2016;17:75.
  281. Villanueva L, Cadden SW, Le Bars D. Diffuse noxious inhibitory controls (DNIC) : evidence for post-synaptic inhibition of trigeminal nucleus caudalis convergent neurons. Brain Res 1984;321:165-168.
  282. Bouhassira D, Le Bars D, Villanueva L. Heterotopic activation of A delta and C fibres triggers inhibition of trigeminal and spinal convergent neurons in the rat. J Physiol 1987;389:301-317.
  283. Clement CI, Keay KA, Podzebenko K, Gordon BD, Bandler R. Spinal sources of noxious visceral and noxious deep somatic afferent drive onto the ventrolateral periaqueductal gray of the rat. J Comp Neurol 2000;425:323-344.
  284. Moutpn LJ, Klop EM, Holstege G. C1-C3 spinal cord projections to periaqueductal gray and thalamus: A quantitative retrograde tracing study in cat. Brain Res 2005;1043:87-94.
  285. Busch V, Jacob W, Juergens T, et al. Functional connectivity between trigeminal and occipital nerves revealed by occipital nerve blockade and nociceptive blink reflexes. Cephalalgia 2006;26:50-55.
  286. Castien R, De Hertogh W. A neuroscience perspective of physical treatment of headache and neck pain. Frontiers Neurol  2019;10:276.
  287. Luedtke K, May A. Stratifying migraine patients based on dynamic pain provocation over the upper cervical spine. J Headache Pain 2017;18:97.
  288. Bragatto MM, Bevilaqua-Grossi D, Benatto MT, et al. Is the presence of neck pain associated with more severe clinical presentation in patients with migraine? A cross-sectional study. Cephalalgia 2019;39:1500-1508.
  289. Liang Z, Galea O, Thomas L, et al. Cervical musculoskeletal impairments in migraine and tension-type headache: A systematic review and meta-analysis. Musculoskel Sci Pract 2019;42:67-83.
  290. Szikszay TM, Hoenick S, von Korn K, et al. Which examination tests detect differences in cervical musculoskeletal impairments in people with migraine? A systematic review and meta-analysis.  Phys Ther 2019;99:549-569.
  291. Viana M, Sances G, Terrazzino S, et al. When cervical pain is actually migraine: An observational study in 207 patients. Cephalalgia 2018;38:383-388.
  292. Johnston MM, Jordan SE, Charles AC. Pain referral patterns of the C1 to C3 nerves: implications for headache disorders. Ann Neurol 2013;74:145-148.
  293. Charles A. The pathophysiology of migraine: Implications for clinical management. Lancet Neurol 2018;17:174-182.
  294. Kemp WJ, Tubbs RS, Cohen-Gadol AA. The innervation of the cranial dura mater: Neurosurgical case correlates and a review of the literature. World Neurosurg 2012;78:505-510.
  295. Prakash S, Rathore C. side-locked headaches : An algorithm-based approach. Headache Pain 2016;17:95.
  296. Ramon C, Mauri G, Vega J, et al. Diagnostic distribution of 100 unilateral, side-locked headaches consulting a specialized clinic. European Neurology 2013;69:289-291.
  297. Hvedstrup J, Kolding LT, Ashina M, Schytz W. Increased neck muscle stiffness in migraine patients with ictal neck pain: A shear wave elastography study. Cephalalgia 2020;40:565-574.
  298. Stefanik JJ, Frey-Law L, Segal NA, et al. The relation of peripheral and central sensitization to muscle co-contraction: The MOST study. Osteoarthritis Cartilage 2020;S1063-4584(20)31053.
  299. Carlsen LN, Munksgaard SB, Nielsen M, et al. Comparison of 3 treatment strategies for medication overuse headache : A randomized clinical trial. JAMA Neurol 2020 [Ahead of print].
  300. Niddam DM, Lai KL, Tsai SÙY, et al. Brain metabolites in chronic migraine patients with medication overuse headache. Cephalalgia 2020;40:851-862.
  301. Arca KN, Singh RBH. The hypertensive headache: A review. Curr Pain Headache Rep 2019;23:30.
  302. Scholten-Peeters GGM, Coppieters MW, Durge TSC, Castien RF. Fluctuations in local and widespread mechanical sensitivity throughout the migraine cycle: a prospective longitudinal study. J Headache Pain 2020;21:16.
  303. Leroux E. La Migraine: Au-Delà du Mal de Tête. 2015; Montréal: Les Éditions du Trécarré.
  304. Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. Lancet Neurol 2008;7:354-361.
  305. Karsan N, Goadsby PJ. Biological insights from the premonitory symptoms of migraine. Nature Reviews Neurol 2018;14:699-710.
  306. Ko MW, Prasad S. Headache, facial pain, and disorders of facial sensation. In: Liu GT, Volpe NJ, Galetta SL. Liu, Volpe, and Galetta’s neuro-ophtalmology: Diagnosis and management, 3rd edition. 2018: Elsevier.
  307. Arickx AN. Overview of headache. In: Mitra R. Principles of rehabilitation medicine. 2019: McGraw-Hill Education.
  308. Krishnaswamy R, Malik BH, Khan S, et al. Anti-CGRP monoclonal antibodies: Breakthrough in migraine therapeutics. Prog Neurol Psych 2019;23:26-33.
  309. Toriyama T, Horiuchi T, Hongo K. Characterization of migraineurs presenting interictal widespread pressure hyperalgesia identified using a tender point count: a cross-sectional study. J Headache Pain 2017;18 :117.
  310. Rizzo AC, Paolucci M, Altavilla R, et al. Daith piercing in a case of chronic migraine: A possible vagal modulation. Front Neurol 2017;8:624.
  311. Bhandari P, Ranjit E, Sapra A, et al. Daith peircing :Wonder treatment or untested fad? Cureus 2020;12:e6978.
  312. Torres-Yaghi Y, Salerian J, Dougherty C. Cardia cephalgia. Curr Pain Headache Rep 2015;19:14.
  313. Lipton RB, Seng EK, Chu MK, et al. The Effect of Psychiatric Comorbidities on Headache-Related Disability in Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study. Headache 2020;60:1683-1696.
  314. Wongtrakul W, Charoenngam N, Ungprasert P. Increased prevalence of irritable bowel syndrome in migraine patients: A systematic review and meta-analysis. Eur J Gastroenterol Hepatol 2021 [Ahead of print].
  315. Liang Z, Thomas L, Jull G, et al. Neck pain associtaed with migraine does not necessarily reflect cervical musculoskeletal dysfunction. Headache 2021;61:882-894.
  316. Aoyama N. Involvement of cervical disability in migraine: a literature review. Br J Pain 2021;15:199-212.
  317. Young AS, Nham B, Bradshaw AP, et al. Clinical oculographic, and vestibular test characteristics of vestibular migraine. Cephalalgia 2021 [Ahead of print].
  318. Ashina M. Migraine. N Engl J Med 2020;383:1866-1876.
  319. Alpuente A, Gallardo VJ, Asskour L, et al. Salivary CGRP can monitor the different migraine phases: CGRP in(dependant) attacks. Cephalalgia 2021 [Ahead of print].
  320. Ahn AH. On the temporal relationship between throbbing migraine pain and arterial pulse. Headache 2010;50:1507-1510.
  321. Mirza AF, Mo J, Holt JL, et al. Is there a relationship between throbbing pain and arterial pulsations? J Neurosci 2012;32:7572-7576.

Laisser un commentaire